The FDA expects Pfizer’s Covid vaccine to be approved for adolescents ages 12-15 by the next WEEK
- According to the New York Times, the Food and Drug Administration is preparing to approve Pfizer’s Covid vaccine for people ages 12-5
- Authorization is expected to occur later this week or early next week
- The Pfizer vaccine was approved in the United States in December for people aged 16 and over
- A study conducted from October through March found that Pfizer’s shot 100% prevented serious illness or death in 12-15 year olds
- However, less than 0.1 percent of all deaths in the United States were among children under the age of 18, raising the question of whether children are shot only for the protection of adults
According to official information from US regulators, Pfizer’s Covid vaccine will be given to teenagers between the ages of 12 and 15 by the end of this week, officials told the New York Times.
The shot was approved for use by anyone aged 16 and over in December, and Pfizer has been in juvenile trials since October last year.
Expanding the study to younger teenagers will allow about 13 million more Americans to be vaccinated. This is a step that some see as critical to achieving herd immunity and improving safety when children return to school.
However, others have questioned whether vaccinating children is worth the risk, as only 471 children under the age of 18 have died from COVID-19, which is 0.1 percent of all US coronavirus deaths.
Approval could be granted later this week and is expected early next week.
According to official information from US regulators, Pfizer’s Covid vaccine will be given to teenagers between the ages of 12 and 15 by the end of this week, officials told the New York Times
If Pfizer’s shot gets the Food and Drug Administration (FDA) green light for younger teenagers, the Centers for Disease Control and Prevention (CDC) will most likely meet the next day and review the results of the Pfizer study.
The agency will then recommend whether or not it believes the vaccine will be safe and effective for 12 to 15 years.
Pfizer announced the results of its youth study on March 31.
The company’s study of 2,260 volunteers found that 100 percent of serious illnesses and deaths from COVID-19 were prevented in teenagers.
In fact, the children showed a stronger immune response to the shot than the 16- to 25-year-old group in which Pfizer had previously tested their vaccine.
A press release on the finding doesn’t mention the teenage side effects, but regulators will comb through the data to make sure there aren’t any red flags before approving the teenage shot.
For some parents who were nervous about their kids returning to school, the shot can’t come soon enough.
Nearly half of U.S. schools were fully face-to-face by March 23, according to an analysis by the Washington Post.
However, the CDC has undoubtedly determined that teachers and students do not need to be vaccinated to return to school safely.
Despite this recommendation, the Biden government has continued to urge states to give priority to vaccination teachers before the majority of school-age children can be vaccinated.